Tag: results

London, UK, June 09, 2025 (GLOBE NEWSWIRE) -- Binaryx, a fractional real estate investing platform, is announcing its move to commercial scale following a successful pilot phase. With $4.4 million in processed investments, with a second-by-second payment of dividends to investors, and 25 tokenized properties launched, Binaryx is contributing to the broader shift toward real estate tokenization — a market projected to unlock $16 trillion in value by 2030.

Los Angeles, CA & Vancouver, BC, June 09, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May 2025, is pleased to announce the appointment of Trevor Bacon and Kellan Grenier, co-founders of Parcl, as Strategic Advisors. Together, they bring deep expertise at the intersection of decentralized finance, synthetic asset creation, and real-world asset tokenization.

Won Prestigious Awards from the Jesse H. Neal Awards, the American Society of Business Publication Editors, National Institute for Health Care Management (NIHCM), NIHCM Foundation and Omeda OX8

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.¹

SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) --  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of DoubleVerify Holdings, Inc. (NYSE: DV) common stock between November 10, 2023 and February 27, 2025, all dates inclusive (the “Class Period”), have until July 21, 2025 to seek appointment as lead plaintiff of the DoubleVerify class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. DoubleVerify Holdings, Inc., No. 25-cv-04332 (S.D.N.Y.), the DoubleVerify class action lawsuit charges DoubleVerify as well as certain of DoubleVerify’s top executives with violations of the Securities Exchange Act of 1934.

Facilities and care team tailored for patients with complex medical needs

In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 trial of D-PLEX100 for preventing surgical site infections (SSIs) in abdominal colorectal surgery patients with large incisions.